首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2289篇
  免费   252篇
  国内免费   16篇
耳鼻咽喉   30篇
儿科学   59篇
妇产科学   37篇
基础医学   302篇
口腔科学   47篇
临床医学   300篇
内科学   504篇
皮肤病学   13篇
神经病学   122篇
特种医学   83篇
外科学   281篇
综合类   41篇
预防医学   237篇
眼科学   59篇
药学   183篇
中国医学   8篇
肿瘤学   251篇
  2023年   18篇
  2022年   13篇
  2021年   61篇
  2020年   40篇
  2019年   53篇
  2018年   90篇
  2017年   54篇
  2016年   49篇
  2015年   73篇
  2014年   93篇
  2013年   118篇
  2012年   149篇
  2011年   154篇
  2010年   97篇
  2009年   97篇
  2008年   127篇
  2007年   141篇
  2006年   101篇
  2005年   111篇
  2004年   127篇
  2003年   126篇
  2002年   96篇
  2001年   60篇
  2000年   67篇
  1999年   47篇
  1998年   27篇
  1997年   21篇
  1996年   12篇
  1995年   14篇
  1994年   11篇
  1993年   19篇
  1992年   35篇
  1991年   35篇
  1990年   22篇
  1989年   29篇
  1988年   18篇
  1987年   24篇
  1986年   16篇
  1985年   8篇
  1984年   13篇
  1983年   10篇
  1982年   7篇
  1981年   10篇
  1980年   6篇
  1979年   7篇
  1977年   13篇
  1976年   7篇
  1972年   5篇
  1971年   6篇
  1970年   5篇
排序方式: 共有2557条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Hormonally inactive adrenocortical carcinoma (ACC) is a rare disease where abdominal discomfort and back pain are common presenting symptoms due to mass effect from a large tumor. Acute kidney injury (AKI) from retroperitoneal tumors has rarely been reported. The most common etiologies include venous thrombosis, ureteral compression, or both. Here, we described a man who presented with AKI from a large retroperitoneal tumor, which was finally diagnosed as a non-functional ACC. The inferior vena cava (IVC) was nearly completely compressed by the large retroperitoneal tumor leading to venous outflow obstruction and AKI. After surgical resection, his urine output increased and renal function recovered. Unfortunately, AKI recurred 2 months later due to recurrence of the tumor. Treatment with a tyrosine kinase inhibitor stabilized his tumor size, and hemodialysis was started. IVC-compression-associated AKI can be the presenting scenario for ACC, a rare but prognostically important aggressive neoplasm.  相似文献   
6.
7.
8.

Objectives

The aim of this study was to evaluate Streptococcus mutans adhesion to fluoride varnishes and subsequent change in biofilm accumulation and acidogenicity.

Methods

After producing fluoride varnish-coated hydroxyapatite discs using Fluor Protector (FP), Bifluorid 12 (BIF), Cavity Shield (CASH), or Flor-Opal Varnish White (FO), S. mutans biofilms were formed on the discs. To assess S. mutans adhesion to the discs, 4-h-old biofilms were analysed. To investigate the change in biofilm accumulation during subsequent biofilm formation, the biomass, colony forming units (CFU), and water-insoluble extracellular polysaccharides (EP) of 46-, 70-, and 94-h-old biofilms were analysed. To investigate the change in acidogenicity, pH values of the culture medium were determined during the experimental period. The amount of fluoride in the culture medium was also determined during the experimental period.

Results

BIF, CASH, and FO affected S. mutans adhesion (67–98% reduction) and subsequent biofilm accumulation in 46-, 70-, and 94-h-old biofilms. However, the reducing effect of the fluoride varnishes on the biomass, CFU count, water-insoluble EP amount, and acid production rate of the biofilms decreased as the biofilm age increased. These results may be related to the fluoride-release pattern of the fluoride varnishes. Of the fluoride varnishes tested, FO showed the highest reducing effect against the bacterial adhesion and subsequent biofilm accumulation.

Conclusions

Our findings suggest that if the results of these experiments are extrapolable to the in vivo situation, then reduced clinical benefit of using fluoride varnishes may occur with time.

Clinical significance

Fluoride varnish application can affect cariogenic biofilm formation but the anti-biofilm activity may be reduced with time.  相似文献   
9.

Background

Treatment of spinal cord injury (SCI)-associated neuropathic pain is challenging, with limited efficacy and no definitive options, and SCI patients often show resistance to pharmacologic treatment. Virtual reality (VR) therapy is a non-invasive, non-pharmacologic alternative with minimal adverse effects.

Objective

To investigate the effect of VR therapy on SCI-associated neuropathic pain in a systematic review.

Methods

Articles needed to 1) be written in English; 2) include adult subjects, with at least half the study population with a SCI diagnosis; 3) involve any form of VR therapy; and 4) assess neuropathic pain by quantitative outcome measures. Articles were searched in MEDLINE/PubMed, CINAHL®, EMBASE, and PsycINFO up to April 2018. Reference lists of retrieved articles were hand-searched. Methodologic quality was assessed by the Physiotherapy Evidence Database Score (PEDro) for randomized controlled trials and Modified Downs and Black Tool (D&B) for all other studies. Level of evidence was determined by using a modified Sackett scale.

Results

Among 333 studies identified, 9 included in this review (n = 150 participants) evaluated 4 methods of VR therapy (virtual walking, VR-augmented training, virtual illusion, and VR hypnosis) for treating neuropathic pain in SCI patients. Each VR method reduced neuropathic pain: 4 studies supported virtual walking, and the other 3 VR methods were each supported by a different study. Combined treatment with virtual walking and transcranial direct current stimulation was the most effective. The quality of studies was a major limitation.

Conclusion

VR therapy could reduce SCI-associated neuropathic pain, although the clinical significance of this analgesic effect is unclear. Clinical trials evaluating VR therapy as standalone and/or adjunct therapy for neuropathic pain in SCI patients are warranted.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号